Search Thermo Fisher Scientific
- Contact Us
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
Next-generation sequencing and advances in real-time PCR (qPCR) throughput have revolutionized the way differential gene expression is analyzed, including variability between gene alleles and differently spliced transcripts, non-coding RNAs, post-transcriptional mutations and editing, and gene fusions. Currently, DNA microarrays are the most widely used method to analyze global patterns of gene expression.
Discover, profile, and functionally analyze more mRNA and non-coding RNAs that regulate cancer with sequencing technologies that provide significant advantages over microarray and flexible real-time PCR assay formats for meeting high, medium, and low throughput needs.
Identify and quantify both known and novel transcripts with a theoretically unlimited dynamic range. Reveal the diversity and subtleties of the transcriptome with Ion RNA-Seq on Ion Proton Sequencer or the 5500xl SOLiD Sequencer.
Determine relative changes in human RNA expression without the need to sequence the entire transcriptome with as little as 5ng of RNA isolated from formalin-fixed, paraffin-embedded (FFPE) samples.
Sensitively detect virtually any gene product in human, mouse, and rat with access to more than 1.3 million predesigned TaqMan Gene Expression Assays.
Identify and analyze new miRNA and Small RNA expression profiles in cancer samples.
Innovative Affymetrix products that help advance the gene expression investigations of cancer researchers via microarray analysis, from discovery to clinical research and validation.
Learn how our solutions are being used to identify novel RNA expression signatures from across the human transcriptome and overcome many of the challenges of working with tumor tissues in the research setting.
Access scientific posters demonstrating new results and methodologies in cancer RNA expression profiling from recent scientific conferences.
Identification of Potential miRNA Biomarkers for Breast Cancer Using TaqMan Pri-miRNA Assays
Learn how our solutions are being used to identify novel RNA expression signatures from across the human transcriptome and overcome many of the challenges of working with tumor tissues in the research setting.
Access scientific posters demonstrating new results and methodologies in cancer RNA expression profiling from recent scientific conferences.
Identification of Potential miRNA Biomarkers for Breast Cancer Using TaqMan Pri-miRNA Assays
For Research Use Only. Not for use in diagnostic procedures.